| 2026-08-13 | Press release | Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update |
| 2026-08-10 | Press release | Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13 |
| 2026-07-30 | Press release | Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel |
| 2026-07-29 | Press release | The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy |
| 2026-07-27 | Press release | Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel |
| 2026-06-26 | Press release | Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenn |
| 2026-06-26 | Press release | Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dy |
| 2026-06-08 | Press release | Capricor Therapeutics to Present at Upcoming Investor Conferences |
| 2026-05-28 | Press release | Capricor Therapeutics Expands Commercial Leadership Team |
| 2026-05-28 | Presentation | Investor Presentation - May 2026 |
| 2026-05-12 | Press release | Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update |
| 2026-05-12 | Press release | PDF |
| 2026-05-07 | Press release | Capricor Therapeutics Takes Legal Action to Protect Patient Access to Deramiocel for Duchenne Muscular Dystrophy |
| Press release | Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12 |
| 2026-03-12 | Press release | Earnings Release |
| 2026-03-12 | Press release | PDF |
| 2026-03-12 | Press release | Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update |
| 2026-03-09 | Press release | Capricor Therapeutics to Present Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Update on Marc |
| 2025-12-11 | Press release | Cell Therapy Deramiocel Meets Primary End Point in Phase 3 DMD Cardiomyopathy Trial |
| Press release | Capricor Therapeutics Presents New Data Demonstrating a Scalable Framework for Loading Therapeutic Oligonucleotides into |
| Press release | Capricor Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update |
| 2025-11-10 | Press release | PDF |
| Press release | Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10 |
| Press release | Capricor Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update |
| 2025-08-11 | Press release | PDF |
| Press release | Capricor Therapeutics to Present Second Quarter 2025 Financial Results and Recent Corporate Update on August 13 |
| Press release | Capricor Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update |
| 2025-05-13 | Press release | PDF |
| Press release | Capricor Therapeutics to Present First Quarter 2025 Financial Results and Recent Corporate Update on May 13 |
| 2025-04-01 | Press release | Capricor Therapeutics to Present at the 2025 Piper Sandler Virtual Cardio Day |
| 2025-03-19 | Press release | Earnings Release |
| 2025-03-19 | Press release | PDF |
| 2025-03-19 | Press release | Capricor Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update |
| 2025-03-11 | Press release | Capricor Therapeutics to Present Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Update on Marc |
| 2024-11-13 | Press release | PDF |
| 2024-11-13 | Press release | Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update |
| 2024-11-12 | Press release | Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual |
| 2024-09-24 | Press release | Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Tre |
| 2024-09-06 | Press release | Capricor Therapeutics to Present at Upcoming Investor and Scientific Conferences |
| 2024-08-07 | Press release | PDF |